Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seppo W Langer

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Cancers|January 11, 2024
Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced DiseaseCecilie Slott, Seppo W Langer, Stine Møller, et al.
Journal of Neuroendocrinology|February 19, 2026
Responses to medical treatment in patients with metastatic unresectable small intestinal neuroendocrine tumors - A single center study of 378 patientsCecilie Slott, Seppo W Langer, Peter Oturai, et al.
European Journal of Hybrid Imaging|June 30, 2021
<sup>18</sup>F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot studyTine Nøhr Christensen, Seppo W Langer, Katrine Engholm Villumsen, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine TumorsAnna Bryan Stensbøl, Jesper Krogh, Pernille Holmager, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2021
Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of ExcellencePernille Holmager, Gro Linno Willemoe, Kirstine Nielsen, et al.
Journal of Neuroendocrinology|August 20, 2021
Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasmsPernille Holmager, Seppo W Langer, Birgitte Federspiel, et al.
Diagnostics (Basel, Switzerland)|November 3, 2020
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine TumorsJonas Baekdal, Jesper Krogh, Marianne Klose, et al.
Lung Cancer (Amsterdam, Netherlands)|August 25, 2012
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancerBjørn H Grønberg, Tudor Ciuleanu, Øystein Fløtten, et al.
Annals of Surgical Oncology|December 19, 2015
Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative StudySven-Petter Haugvik, Eva Tiensuu Janson, Pia Österlund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung CancerAnders Olin, Claes N Ladefoged, Natasha H Langer, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Cancers|January 11, 2024
Outlook for 615 Small Intestinal Neuroendocrine Tumor Patients: Recurrence Risk after Surgery and Disease-Specific Survival in Advanced DiseaseCecilie Slott, Seppo W Langer, Stine Møller, et al.
Journal of Neuroendocrinology|February 19, 2026
Responses to medical treatment in patients with metastatic unresectable small intestinal neuroendocrine tumors - A single center study of 378 patientsCecilie Slott, Seppo W Langer, Peter Oturai, et al.
European Journal of Hybrid Imaging|June 30, 2021
<sup>18</sup>F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot studyTine Nøhr Christensen, Seppo W Langer, Katrine Engholm Villumsen, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine TumorsAnna Bryan Stensbøl, Jesper Krogh, Pernille Holmager, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 16, 2021
Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of ExcellencePernille Holmager, Gro Linno Willemoe, Kirstine Nielsen, et al.
Journal of Neuroendocrinology|August 20, 2021
Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasmsPernille Holmager, Seppo W Langer, Birgitte Federspiel, et al.
Diagnostics (Basel, Switzerland)|November 3, 2020
Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine TumorsJonas Baekdal, Jesper Krogh, Marianne Klose, et al.
Lung Cancer (Amsterdam, Netherlands)|August 25, 2012
A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancerBjørn H Grønberg, Tudor Ciuleanu, Øystein Fløtten, et al.
Annals of Surgical Oncology|December 19, 2015
Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative StudySven-Petter Haugvik, Eva Tiensuu Janson, Pia Österlund, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung CancerAnders Olin, Claes N Ladefoged, Natasha H Langer, et al.
Pageof 12